论文部分内容阅读
目的:探讨茵栀黄口服液用于新生儿黄疸临床效果。方法:选取近1年所收治的90例新生儿黄疸患者,采取随机数字表法,将其平均分为观察组和对照组,每组患儿45例,两组患儿给予常规蓝光照射、西药治疗,在此基础上,观察组患儿采取菌栀黄口服液辅佐治疗,对比两组疗效。结果:观察组患儿总有效率100%,明显高于对照组(80%),差异具有统计学意义(X2=10.183,P=0.006);观察组患儿黄疸消退时间、住院时间明显优于对照组,差异具有统计学意义(P<0.05)。结论:茵栀黄口服液用于新生儿黄疸治疗中,可改善患儿黄疸症状,缩短治疗时间,并且用药安全,值得临床上推广应用。
Objective: To investigate the clinical effect of Yinzhihuang oral solution on neonatal jaundice. Methods: A total of 90 neonates with jaundice admitted in the past year were enrolled in this study. Random number table was used to divide them into observation group and control group. There were 45 children in each group. The two groups were given routine blue light irradiation and Western medicine Treatment, on this basis, the observation group to take bacteria Zhizhi Huang oral adjuvant therapy, the two groups were compared. Results: The total effective rate in observation group was 100%, which was significantly higher than that in control group (80%), the difference was statistically significant (X2 = 10.183, P = 0.006). The observation group had significantly better jaundice regression and hospital stay Control group, the difference was statistically significant (P <0.05). Conclusion: Yinzhihuang Oral Liquid can be used in neonatal jaundice to improve the symptoms of jaundice in children and shorten the treatment time, and the medication is safe and worthy of clinical application.